SCHEMBL22249795

SCHEMBL22249795

COc1ccc(Cl)cc1-c1ncncc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
USP2 O75604 1/20 0.43
PRNP P04156 1/20 0.43
PPARG P37231 1/20 0.43
MAPK10 P53779 1/20 0.43
NCOA2 Q15596 1/20 0.43
NCOA1 Q15788 1/20 0.43
HSD17B10 Q99714 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
SCN9A Q15858 3/20 0.42
CYP17A1 P05093 2/20 0.41
KCNH2 Q12809 1/20 0.41
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22249923 0.78 IDO1 (0.46) KMT2ANPSR1HSD17B10
SCHEMBL29196619 0.73 RECQL (0.49) HPGDMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL30855384 0.73 RECQL (0.49) HPGDMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL31298042 0.72 AURKA (0.45) LRRK2
SCHEMBL7699644 0.72 ALDH1A1 (0.56) HPGDMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL20339204 0.71 ALDH1A1 (0.51) MEN1KMT2AKDM4EALDH1A1LMNA
SCHEMBL29785340 0.71 ALDH1A1 (0.51) MEN1KMT2AKDM4EALDH1A1LMNA
SCHEMBL3311451 0.70 CYP1A2 (0.43) HPGDKMT2ASMN1; SMN2NPSR1KDM4E
SCHEMBL5128528 0.70 RECQL (0.43) HPGDMEN1KMT2ASMN1; SMN2NPSR1
SCHEMBL27584266 0.69 ALDH1A1 (0.52) HPGDMEN1KMT2ASMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ODC1 HPGD 2194/4885MEN1 589/4885KMT2A 3007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.